Innovative Generative Chemistry Drives Gut-Restricted PHD Inhibitor Development for IBD Treatments Insilico Medicine leverages generative chemistry to develop gut-restricted PHD inhibitors, offering new hope for treating inflammatory bowel disease.

Innovative Generative Chemistry Drives Gut-Restricted PHD Inhibitor Development for IBD Treatments #United_States #Cambridge #IBD_Treatments #Insilico_Medicine #PHD_Inhibitors